id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-1159-0001,FDA,FDA-2025-N-1159,"Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Plazomicin Test
System",Rule,Final Rule,2025-05-29T00:00:00Z,2025,5,2025-05-29T00:00:00Z,,2025-05-29T18:34:10Z,2025-09638,0,0,09000064b8dc76a2